GlassScriptPhysician profile
Michael Amendola
NPI 1427267822
$18,346.86
in general payments reported to CMS, 2019-2025
26 companies · $2,590 in 2025
The $2,590 reported for 2025 was more than what 75% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,609 · 2020: $1,713 · 2021: $2,640 · 2022: $3,388 · 2023: $3,415 · 2024: $992 · 2025: $2,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,652 · Travel and Lodging: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,651.70 |
| Travel and Lodging | $345.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,277.71 | 2021-2025 | Endurant Iis, Mo.Ma Ultra, Valiant Captivia |
| Bolton Medical INC | $2,282.90 | 2021-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Medtronic Vascular, INC. | $1,958.89 | 2019-2020 | |
| Tactile Systems Technology INC | $1,815.08 | 2019-2023 | Flexitouch Plus, Entre Plus |
| Bard Peripheral Vascular, INC. | $1,015.30 | 2019-2023 | Crosser Iq |
| Penumbra, INC. | $923.06 | 2019-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $897.30 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Astrazeneca Pharmaceuticals LP | $799.25 | 2023-2024 | Andexxa |
| Endologix LLC | $494.94 | 2019-2023 | Alto Abdominal Stent Graft System |
| Cook Medical LLC | $494.53 | 2019-2025 | Cook |
| Abbott Laboratories | $223.63 | 2019-2024 | Esprit, Perclose Prostyle |
| Veryan Medical Incorporated | $200.50 | 2021 | |
| Shockwave Medical, INC | $178.15 | 2022 | |
| Silk Road Medical, INC. | $146.41 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Electronic Waveform Lab, INC. | $103.15 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $95.03 | 2023 | Cysview |
| Imperative Care, INC | $91.20 | 2023 | Symphony Catheter |
| Karl Storz Endoscopy-America | $85.98 | 2023 | Flex-X |
| Alexion Pharmaceuticals, INC. | $84.11 | 2021 | |
| Inari Medical, INC. | $46.89 | 2022 | |
| Janssen Pharmaceuticals, INC | $38.00 | 2022 | |
| Intuitive Surgical, INC. | $32.82 | 2023 | |
| Werfen USA LLC | $20.80 | 2022 | |
| Portola Pharmaceuticals, LLC | $14.15 | 2020 | |
| Convatec INC. | $13.95 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Amendola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.